Search

The article discusses the pervasive and potentially harmful effects of viruses on human health. Topics include Cancer-Virus Connection, which highlights how viruses like HPV and Epstein-Barr are linked to specific cancers; Viral Transmission, detailing how viruses spread through sneezing, sexual contact, and needle sharing; and Health Impact, focusing on how viruses can disrupt cellular function and contribute to cancer development by causing oxidative stress and inflammation.

2024 NOV 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Epstein-Barr virus have been presented. According to news reporting [...]

2024 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

2024 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Epstein-Barr virus are presented in a new report. According [...]

2024 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Epstein-Barr virus are presented in a new report. According [...]

Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration(NMPA) in China [...]

2024 JUL 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Epstein-Barr virus. According to news originating from [...]

2024 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Epstein-Barr virus is now available. According to news [...]

2024 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Epstein-Barr virus. According to news reporting from [...]

2024 JUN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Researchers detail new data in Epstein-Barr virus. According to news originating from Montreal, Canada, [...]

2024 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Epstein-Barr virus. According to news reporting originating [...]

2024 MAR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

2024 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Epstein-Barr virus. According to news reporting from [...]

2024 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Epstein-Barr virus is the subject of a new report. [...]

2024 JAN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Epstein-Barr virus. According to news reporting from [...]

Byline: Jyotiman. Nath, Gautam. Sarma, Ankita. Das, Kishore. Das, Lopamudra. Kakati Lymphoepithelial carcinoma (LEC) of the larynx is a rare tumor comprising 0.2% of all laryngeal neoplasms. To our knowledge, [...]

2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on peripheral T-cell lymphoma are presented in a new report. [...]

2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Epstein-Barr virus is the subject of a new report. [...]

Viracta Therapeutics plans to highlight new preliminary clinical and preclinical data from studies of nanatinostat and valganciclovir, its all-oral investigational therapy targeting Epstein-Barr virus associated cancers, during an R&D Day, [...]

Byline: Danika. Corless, Konstandina. Koklanis, Linda. Malesic Epstein-Barr virus (EBV), a herpes virus with a global prevalence exceeding 95%, is infrequently associated with ocular manifestations. We present a case of [...]

This article from Woman & Home provides health advice from GP Dr Pixie McKenna. The first question addresses the possibility of mumps in a child who did not receive the MMR vaccine. Dr. McKenna explains that mumps can present with mild symptoms such as fever and fatigue, and swollen testicles can occur as a complication. The second question discusses an open wound on the breast that won't heal, and Dr. McKenna advises seeking medical attention to rule out any underlying issues. The final question addresses Alzheimer's disease and the use of cholinesterase inhibitors to manage symptoms. Dr. McKenna explains that while there is no cure, these medications can help reduce behavioral and psychological symptoms. The article also includes a section on glandular fever and osteoporosis. [Extracted from the article]

Researchers at Lausanne University Hospital and University of Lausanne conducted a study on the Epstein-Barr virus (EBV) and its potential subclinical effects in the adult general population. The study focused on the association between EBV immune response and perceived fatigue in a community-dwelling cohort, revealing positive correlations between EBV immune response and fatigue levels, as well as myelin content in the brain. The findings suggest a potential role of EBV chronic immune response in perceived fatigue and hint towards a protective role of myelination specific for men. [Extracted from the article]

Researchers at the University of Florida have reported new findings on the role of acute Epstein-Barr virus (EBV) infection in the production of autoantibodies in Sjogren's disease. The study examined a patient with primary EBV infection who developed Sjogren's disease and various autoantibodies. The research suggests that EBV infection may promote the production of specific autoantibodies through different mechanisms. This peer-reviewed study provides insights into the potential link between EBV infection and autoantibody production in autoimmune diseases. [Extracted from the article]

A recent study conducted at Stanford University focused on distinguishing Epstein Barr Virus-positive mucocutaneous ulcer (EBVMCU) from EBV-positive diffuse large B cell lymphoma (DLBCL) using targeted next-generation sequencing (NGS) to explore genetic alterations. The research identified various genetic variants in EBVMCU cases, with loss of function TET2 variants being the most common. Further studies are needed to confirm these findings and determine their clinical significance in the pathogenesis of this disorder. This peer-reviewed research sheds light on the genetic landscape of EBVMCU and its implications for differential diagnosis with DLBCL. [Extracted from the article]

A recent meta-analysis conducted by researchers at the University of Hong Kong's LKS Faculty of Medicine has identified a significant link between specific Epstein-Barr virus (EBV) variants and nasopharyngeal carcinoma (NPC) in southern China. NPC, commonly known as 'Cantonese Cancer', disproportionately affects middle-aged men in regions like Guangdong and Hong Kong. The study suggests that understanding the role of EBV in NPC's development could lead to improved screening and diagnostic methods, potentially enhancing patient outcomes in endemic areas. [Extracted from the article]

Researchers at the University of California Los Angeles (UCLA) have conducted a study on Human Herpesvirus 8, specifically focusing on the structures of Epstein-Barr Virus (EBV) and Kaposi's Sarcoma-associated Herpesvirus (KSHV) virions. The study utilized cryogenic electron tomography to reveal species-specific features of the tegument and envelope of these viruses. The research highlights differences in the architecture of tegument and envelope among human herpesviruses, providing insights into their cell tropism and infection mechanisms. This study has been peer-reviewed and offers valuable information for understanding the complexities of these viruses. [Extracted from the article]

A study conducted in Genova, Italy, focused on Epstein-Barr virus (EBV) reactivation in pediatric patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HCT). The research aimed to investigate the impact of recipient/donor-related factors on EBV reactivations and the effectiveness of pre-emptive therapy using rituximab. Results showed that delayed immune reconstitution was a risk factor for EBV reactivation, and the approach used in providing pre-emptive therapy reduced the number of children who needed rituximab, effectively lowering the incidence rate of post-transplant lymphoproliferative disease (PTLD). [Extracted from the article]

A recent study conducted in the Peruvian Amazon by researchers at the University of Virginia aimed to determine the prevalence of acute febrile illness (AFI) caused by primary Epstein-Barr virus (EBV) infection. The study found that while EBV DNA was present in both febrile cases and afebrile controls, it was not correlated with classic infectious mononucleosis (IM) symptoms. The research concluded that IM due to primary EBV infection was not a significant cause of AFI in the Peruvian Amazon, despite initial high rates of test positivity. For more information, the full article can be accessed in The American Journal of Tropical Medicine and Hygiene. [Extracted from the article]

A recent study conducted by researchers at the Universidad Industrial de Santander sheds light on infectious mononucleosis caused by the Epstein-Barr Virus, a common infection among adolescents and young adults. The study highlights a case of the disease in an unusual age group with liver complications that resolved with treatment. The researchers recommend long-term follow-up for patients with infectious mononucleosis to detect complications early. [Extracted from the article]

A recent study conducted at Wenzhou Medical University in China focused on understanding the genetic and immune cell dynamics in systemic lupus erythematosus (SLE) patients with Epstein-Barr virus (EBV) infection. The researchers identified key genes and immune cells in SLE patients with EBV infection using machine learning algorithms and differential gene expression analyses. The study highlighted IFI27 as a key gene influencing CD4 CTL and B cell subtypes in SLE patients with EBV infection, providing potential targets for diagnostic and therapeutic strategies. This research enhances the understanding of the molecular mechanisms linking SLE and EBV infection. [Extracted from the article]

The article from Reactions Weekly discusses two case reports involving patients with Epstein-Barr virus (EBV) positive post-transplant lymphoproliferative disease who experienced adverse reactions to tabelecleucel treatment. One patient developed grade 2 liver transplant rejection, while the other patient showed lack of efficacy with the therapy. Despite receiving tabelecleucel, one patient died due to disease progression, indicating lack of efficacy, while another patient experienced grade 2 liver transplant rejection. The study highlights the challenges in treating relapsed or refractory EBV positive post-transplant lymphoproliferative disease with tabelecleucel. [Extracted from the article]

A recent study conducted at Ahvaz Jundishapur University of Medical Sciences in Iran investigated the prevalence of Epstein-Barr virus (EBV) in gastric cancer patients. The study found a low prevalence of EBV-associated gastric cancer in Iran, with only 7% of cases testing positive for EBV. The research suggests that differences in EBV occurrence among countries may be influenced by epidemiological variables and dietary practices, highlighting the need for further comprehensive studies to better understand the etiology of EBV-associated gastric cancer. [Extracted from the article]